On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
WednesdayNov 01, 2017 11:41 am

QualityStocksNewsBreaks – 92 Resources Corp. (TSX.V: NTY) (OTCQB: RGDCF) (FSE: R9G2) Likely to Profit Through Supply of Lithium to EV Manufacturers

The increased need for lithium, driven by the demand for electric vehicles (EV), is good news for 92 Resources Corp. (TSX.V: NTY) (OTCQB: RGDCF) (FSE: R9G2). As the automobile manufacturers scramble to secure enough lithium for EV production, the value of junior lithium mining companies like 92 Resources climbs. An article discussing this reads: “With concern about dwindling supplies of lithium carbonate growing, prices for the compound used in the cathodes of batteries have more than doubled since 2015. Prices are expected to hit US$12,000 per tonne, according to the Driving Disruption report issued by investment bank UBS, and while…

Continue Reading

WednesdayNov 01, 2017 10:10 am

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Receives Extensive Patent Allowance from USPTO

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP), a drug delivery platform innovator, announced late yesterday that it has received a new Notice of Allowance from the United States Patent and Trademark Office (“USPTO”) related to the use of its innovative DehydraTECH™ technology as a delivery platform for the full list of active pharmacological ingredients requested, including all cannabinoids, fat-soluble vitamins, nonsteroidal anti-inflammatory pain medications (“NSAIDs”) and nicotine. The company expects formal patent issuance within three to four months, with provided protections extending through 2035 or later. “This wide-ranging patent allowance from the USPTO exceeds our expectations,” Chris Bunka, chief executive…

Continue Reading

WednesdayNov 01, 2017 9:45 am

QualityStocksNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Announces Three Additions to Board of Directors

Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning expanded its board of directors, announcing its appointment of Delray Wannemacher and Patrick Leung as independent directors and Keevin Gillespie as an executive director, effective immediately. Per the update, Wannemacher and Leung will also serve on the company’s audit committee alongside recently appointed chief financial officer Paul Dickman. “We are extremely pleased to welcome Delray, Patrick and Keevin to the ChineseInvestors.com, Inc.'s Board of Directors,” Warren Wang, chief executive officer of ChineseInvestors.com, stated in the news release. “Their financial and industry experience make these gentlemen excellent choices for the Company's Board…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered